Why SK Life Science Labs’ AACR 2026 data could put targeted protein degradation back in the oncology spotlight
What Doximity (NYSE: DOCS) CFO resignation means for governance, capital allocation, and investor confidence
Read More Pharma Industry News BillionToOne’s Unity Fetal Risk screen reshapes cystic fibrosis prenatal testing with early therapeutic pathways BillionToOne’s Unity Fetal Risk Screen delivers 100% sensitivity in cystic fibrosis prenatal detection, unlocking earlier treatment options for families. bySoujanya RaviSeptember 23, 2025